Schwann Cells	11
Olfactory Ensheathing Cells Behaviors , from Interacting with Astrocyte ,	29
Olfactory Ensheathing Cells Behaviors	29
Astrocyte	90
Similar Improvements	109
Contused Rat Spinal Cord 's Motor Function Bing Cang Li & Chuan Xu & Jie Yuan Zhang & Yue Li & Zhao Xia Duan Abstract In recent years , cell behaviors of Schwann cells -LRB- SCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB- when interacting with astrocytes was appraised qualitatively in vitro and in spinal cord injury model of dorsal crush and transection and in normal white matter	133
Contused Rat	133
Spinal Cord 's Motor Function	146
Spinal Cord 's	146
Bing Cang Li & Chuan Xu & Jie Yuan Zhang & Yue Li & Zhao Xia Duan Abstract In recent years , cell behaviors of Schwann cells -LRB- SCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB- when interacting with astrocytes was appraised qualitatively in vitro and in spinal cord injury model of dorsal crush and transection and in normal white matter	176
Bing Cang Li & Chuan Xu & Jie Yuan Zhang & Yue Li & Zhao Xia Duan Abstract	176
recent years , cell behaviors of Schwann cells -LRB- SCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB- when interacting with astrocytes was appraised qualitatively in vitro	255
recent years	255
cell behaviors of Schwann cells -LRB- SCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB- when interacting with astrocytes was appraised qualitatively in vitro	269
cell behaviors	269
Schwann cells -LRB- SCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB-	287
Schwann cells	287
SCs	302
olfactory ensheathing cells	311
OECs	340
astrocytes	368
spinal cord injury model of dorsal crush and transection	423
spinal cord injury model	423
dorsal crush and transection	451
normal white matter	487
this study , with an attempt to select a candidate for cell-mediated repair of the spinal cord injury	511
this study	511
an attempt to select a candidate for cell-mediated repair of the spinal cord injury	528
a candidate	549
cell-mediated repair of the spinal cord injury	565
cell-mediated repair	565
the spinal cord injury	589
SCs or OECs	613
contused spinal cord in adult rats	648
contused spinal cord	648
adult rats	672
The interaction with host astrocytes	684
The interaction	684
host astrocytes	705
3 and 6 weeks after transplantation	737
3 and 6 weeks	737
transplantation	757
light and electron microscope	779
The motor function of the rat	810
The motor function	810
the rat	832
the BBB locomotor rating scale	859
cortical somatosensory	894
potentials -LRB- CSEP -RRB- recording	924
potentials -LRB- CSEP -RRB-	924
potentials	924
CSEP	936
SCs cord	960
the astrocytes	970
proliferation and hypertrophy	995
The myelinated axons	1026
the groups	1067
the glial membrane	1081
OECs cord	1108
astrocytes	1119
the proliferation and hypertrophy	1146
The myelinated axons	1181
groups	1224
the scar tissue	1234
SCs graft , compared with OECs graft ,	1251
SCs graft	1251
OECs graft	1276
more enhanced glial fibrillary acidic protein -LRB- GFAP -RRB- immunoreactivity with a distinct astroglial border between the normal and injured tissues	1296
more	1296
glial fibrillary acidic protein -LRB- GFAP -RRB- immunoreactivity	1310
GFAP	1343
a distinct astroglial border between the normal and injured tissues	1371
a distinct astroglial border	1371
the normal and injured tissues	1408
The distribution of SCs	1440
The distribution	1440
SCs	1460
that of OECs	1509
that	1509
OECs	1517
SCs	1523
weaker NF immunoreactivity and functional recovery	1535
weaker NF immunoreactivity	1535
functional recovery	1566
OECs	1598
no significant differences between the two groups	1608
no significant differences	1608
the two groups	1643
the statistical analysis	1674
we	1703
this	1712
first time to compare behaviors of SCs and OECs in the contusion model	1720
behaviors of SCs and OECs	1742
behaviors	1742
SCs and OECs	1755
the contusion model	1771
the data	1796
cell behaviors of SCs and OECs	1837
cell behaviors	1837
SCs and OECs	1855
astrocyte	1902
both cell types	1913
the motor function of the contused rats	1941
the motor function	1941
the contused rats	1963
Introduction	1983
spinal cord injury -LRB- SCI -RRB-	2002
spinal cord injury	2002
SCI	2022
a series of cellular and molecular events	2028
a series	2028
cellular and molecular events	2040
glial scar	2081
Astrocytes	2093
response	2121
injury	2133
the synthesis of glial fibrillary acidic protein -LRB- GFAP -RRB- -LRB- Fawcet and Asher 1999 -RRB-	2155
the synthesis	2155
glial fibrillary acidic protein -LRB- GFAP -RRB- -LRB- Fawcet and Asher 1999 -RRB-	2172
glial fibrillary acidic protein -LRB- GFAP -RRB-	2172
glial fibrillary acidic protein	2172
GFAP	2205
Fawcet and Asher 1999	2212
Fawcet	2212
Asher 1999	2223
The most dramatic responses of astrocytes	2236
The most dramatic responses	2236
astrocytes	2267
the formation of the glial scar , which accompanied by the extensive hypertrophy of the cell body and cytoplasmic processes	2287
the formation	2287
the glial scar , which accompanied by the extensive hypertrophy of the cell body and cytoplasmic processes	2304
the glial scar	2304
the extensive hypertrophy of the cell body and cytoplasmic processes	2341
the extensive hypertrophy	2341
the cell body and cytoplasmic processes	2370
the cell body	2370
cytoplasmic processes	2388
this scar	2420
necrotic tissue	2452
non-neural cells	2480
the tissue cavity resulting from injury -LRB- Eddleston and Mucke 1993 -RRB-	2505
the tissue cavity	2505
injury -LRB- Eddleston and Mucke 1993 -RRB-	2538
injury	2538
Eddleston and Mucke 1993	2546
Eddleston	2546
Mucke 1993	2560
it	2573
axonal regeneration -LRB- Silver and Miller 2004 ; Pekny and Nilsson 2005 -RRB-	2590
axonal regeneration	2590
Silver and Miller 2004 ; Pekny and Nilsson 2005	2611
Silver and Miller 2004 ; Pekny and Nilsson	2611
Silver and Miller 2004	2611
Silver	2611
Miller 2004	2622
Pekny and Nilsson	2635
Pekny	2635
Nilsson	2645
2005	2653
Both Schwann cells -LRB- SCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB-	2660
Both Schwann cells -LRB- SCs -RRB-	2660
Both Schwann cells	2660
SCs	2680
olfactory ensheathing cells -LRB- OECs -RRB-	2689
olfactory ensheathing cells	2689
OECs	2718
cellular environments that support the growth of damaged axons following transplantation into injured spinal cord , so as both have been widely advocated for transplant-mediated repair of SCI of animals -LRB- Andrews and Stelzner 2007 ; Fouad et al. 2005 ; Li et al. 2003 ; Lu et al. 2002 ; Lankford et al. 2002 -RRB- and human -LRB- Huang et al. 2003 ; Feron et al. 2005 ; Lima et al. 2006 ; Mackay-Sim et al. 2008 -RRB-	2732
cellular environments	2732
the growth of damaged axons following transplantation into injured spinal cord	2767
the growth	2767
damaged axons following transplantation into injured spinal cord	2781
damaged axons	2781
transplantation into injured spinal cord	2805
transplantation	2805
injured spinal cord	2826
both	2853
transplant-mediated repair of SCI of animals -LRB- Andrews and Stelzner 2007 ; Fouad et al. 2005 ; Li et al. 2003 ; Lu et al. 2002 ; Lankford et al. 2002 -RRB- and human -LRB- Huang et al. 2003 ; Feron et al. 2005 ; Lima et al. 2006 ; Mackay-Sim et al. 2008 -RRB-	2889
transplant-mediated repair	2889
SCI of animals -LRB- Andrews and Stelzner 2007 ; Fouad et al. 2005 ; Li et al. 2003 ; Lu et al. 2002 ; Lankford et al. 2002 -RRB- and human -LRB- Huang et al. 2003 ; Feron et al. 2005 ; Lima et al. 2006 ; Mackay-Sim et al. 2008 -RRB-	2919
SCI	2919
animals -LRB- Andrews and Stelzner 2007 ; Fouad et al. 2005 ; Li et al. 2003 ; Lu et al. 2002 ; Lankford et al. 2002 -RRB- and human -LRB- Huang et al. 2003 ; Feron et al. 2005 ; Lima et al. 2006 ; Mackay-Sim et al. 2008 -RRB-	2926
animals	2926
Andrews and Stelzner 2007 ; Fouad et al. 2005 ; Li et al. 2003 ; Lu et al. 2002 ; Lankford et al. 2002	2935
Andrews and Stelzner 2007 ; Fouad et al. 2005 ; Li et al. 2003 ; Lu et al. 2002 ; Lankford et al.	2935
Andrews and Stelzner 2007	2935
Andrews	2935
Stelzner 2007	2947
Fouad et al. 2005	2962
Fouad	2962
et al.	2968
2005	2975
Li et al. 2003	2981
Li	2981
et al.	2984
2003	2991
Lu et al. 2002	2997
Lu	2997
et al.	3000
2002	3007
Lankford et al.	3013
Lankford	3013
et al.	3022
2002	3029
human	3039
Huang	3046
et al. 2003 ; Feron et al. 2005 ; Lima et al. 2006 ; Mackay-Sim et al. 2008	3052
et al. 2003 ; Feron et al. 2005 ; Lima et al. 2006 ; Mackay-Sim et al.	3052
et al. 2003	3052
et al.	3052
2003	3059
Feron et al. 2005	3065
Feron	3065
et al.	3071
2005	3078
Lima et al. 2006	3084
Lima	3084
et al.	3089
2006	3096
Mackay-Sim et al.	3102
Mackay-Sim	3102
et al.	3113
2008	3120
SCs and OECs	3133
common growth factor responses -LRB- Pollock et al. 1999 -RRB- , antigenic and morphological characteristics -LRB- Franceschini and Barnett 1996 -RRB- , and transcriptional regulation -LRB- Smith et al. 2001 -RRB-	3152
common growth factor responses -LRB- Pollock et al. 1999 -RRB- , antigenic and morphological characteristics -LRB- Franceschini and Barnett 1996 -RRB- , and transcriptional regulation	3152
common growth factor responses -LRB- Pollock et al. 1999 -RRB-	3152
common growth factor responses	3152
Pollock	3184
et al. 1999	3192
et al.	3192
1999	3199
antigenic and morphological characteristics -LRB- Franceschini and Barnett 1996 -RRB-	3206
antigenic and morphological characteristics	3206
Franceschini and Barnett 1996	3251
Franceschini	3251
Barnett 1996	3268
transcriptional regulation	3287
Smith	3315
et al. 2001	3321
et al.	3321
2001	3328
they	3335
reactive astrocyte response	3359
Lakatos et al. 2000 ; Fairless et al. 2005	3397
Lakatos	3397
et al. 2000 ; Fairless et al. 2005	3405
et al. 2000	3405
et al.	3405
2000	3412
Fairless et al. 2005	3418
Fairless	3418
et al.	3427
2005	3434
vivo -LRB- Lakatos et al. 2003 ; Santos-Silva et al. 2007 -RRB-	3447
vivo	3447
Lakatos	3453
et al. 2003 ; Santos-Silva et al. 2007	3461
et al. 2003 ; Santos-Silva et al.	3461
et al. 2003	3461
et al.	3461
2003	3468
Santos-Silva et al.	3474
Santos-Silva	3474
et al.	3487
2007	3494
assays	3516
both SCs and OECs	3533
SCs	3538
OECs	3546
astrocyte monolayers	3566
OECs	3597
an area containing astrocytes	3620
an area	3620
astrocytes	3639
Astrocytes	3651
hypertrophy when	3670
hypertrophy	3670
contact with SCs	3690
contact	3690
SCs	3703
OECs -LRB- Lakatos et al. 2000 -RRB-	3720
OECs	3720
Lakatos	3726
et al. 2000	3734
et al.	3734
2000	3741
It	3748
astrocytes	3788
OECs but not SCs after injection	3811
OECs but not SCs	3811
injection	3834
normal spinal cord -LRB- Santos-Silva et al. 2007 -RRB-	3849
normal spinal cord	3849
Santos-Silva	3869
et al. 2007	3882
et al.	3882
2007	3889
this study	3899
SCs and OECs	3911
olfactory bulb and sciatic nerve of transgenic rat	3946
olfactory bulb and sciatic nerve	3946
transgenic rat	3982
green fluorescence protein -LRB- GFP -RRB- transplanted into the contused spinal cord	4002
green fluorescence protein	4002
GFP	4030
the contused spinal cord	4053
the	4053
spinal cord	4066
Their behaviors when interacting with astrocyte and glial scar	4079
Their behaviors	4079
astrocyte and glial scar	4117
astrocyte	4117
glial scar	4131
semi-quantitative analysis and ultrastructural description	4162
semi-quantitative analysis	4162
ultrastructural description	4193
the motor function of the contused rat	4236
the motor function	4236
the contused rat	4258
the BBB locomotor rating scale	4288
cortical somatosensory	4323
potentials -LRB- CSEP -RRB- recording	4353
potentials -LRB- CSEP -RRB-	4353
potentials	4353
CSEP	4365
Our results	4382
the previous reports	4402
OECs	4428
glial scar	4451
more	4471
SCs	4493
GFAP immunocytochemistry	4505
it	4540
SCs	4560
collagen membrane	4582
hypertrophic astrocytes	4619
the OECs	4650
SCs	4677
weaker neurofilament -LRB- NF -RRB- immunoreactivity and functional recovery compared to OECs	4689
weaker neurofilament -LRB- NF -RRB- immunoreactivity	4689
weaker neurofilament	4689
NF	4711
immunoreactivity	4715
functional recovery compared to OECs	4736
functional recovery	4736
OECs	4768
both cells	4774
the motor function of contused rat spinal cord	4799
the motor function	4799
contused rat spinal cord	4821
These results	4847
candidate transplant cells in human SCI therapy	4894
candidate transplant cells	4894
human SCI therapy	4924
the future	4945
Materials and Methods Preparation of SCs and OECs from GFP Rats Sciatic nerves and olfactory bulbs	4958
Materials	4958
Methods Preparation of SCs and OECs from GFP Rats Sciatic nerves and olfactory bulbs	4972
Methods Preparation	4972
SCs and OECs from GFP Rats Sciatic nerves and olfactory bulbs	4995
SCs and OECs	4995
GFP Rats Sciatic nerves and olfactory bulbs	5013
GFP Rats Sciatic nerves	5013
olfactory bulbs	5041
adult GFP rats	5075
SCs	5091
modified method described in Lankford et al.	5124
modified method	5124
Lankford	5153
et al.	5162
2002	5169
nerves	5184
scalpel blades	5223
incubation	5245
45 min in Collagenase A and Collagenase D -LRB- 1 mg/ml each , Roche , Indianapolis , IN -RRB-	5260
45 min	5260
Collagenase A and Collagenase D -LRB- 1 mg/ml each , Roche , Indianapolis , IN -RRB-	5270
Collagenase A	5270
Collagenase D -LRB- 1 mg/ml each , Roche , Indianapolis , IN -RRB-	5288
Collagenase D	5288
1 mg/ml each , Roche , Indianapolis	5303
1 mg/ml	5303
each	5311
Roche , Indianapolis	5317
15 min in 0.5 mg/ml trypsin -LRB- Worthington , Lakewood , NJ -RRB-	5355
15 min	5355
0.5 mg/ml trypsin -LRB- Worthington , Lakewood , NJ -RRB-	5365
0.5 mg/ml trypsin	5365
Worthington	5384
Lakewood	5397
NJ	5407
fire polished pipettes	5444
Non-dissociated tissue	5468
the cell suspension	5516
a 70-μm cell strainer -LRB- Falcon -RRB-	5541
a 70-μm cell strainer	5541
Falcon	5564
OECs	5573
detail in Sasaki et al. 2004	5608
detail	5608
Sasaki et al. 2004	5618
et al. 2004	5625
et al.	5625
2004	5632
the caudal two thirds of the olfactory bulbs	5647
the caudal two thirds	5647
the olfactory bulbs	5672
meninges and white matter	5714
meninges	5714
white matter	5727
scalpel blades	5753
25 min in collagenase A -LRB- 0.75 mg/ml Roche -RRB- , collagenase D -LRB- 0.75 mg/ml , Roche -RRB- , and papain -LRB- 12 U/ml , Worthington -RRB-	5787
25 min	5787
collagenase A -LRB- 0.75 mg/ml Roche -RRB- , collagenase D -LRB- 0.75 mg/ml , Roche -RRB- , and papain -LRB- 12 U/ml , Worthington -RRB-	5797
collagenase A -LRB- 0.75 mg/ml Roche -RRB-	5797
collagenase A	5797
0.75 mg/ml Roche	5812
collagenase D -LRB- 0.75 mg/ml , Roche -RRB-	5831
collagenase D	5831
0.75 mg/ml	5846
Roche	5858
papain -LRB- 12 U/ml , Worthington -RRB-	5870
papain	5870
12 U/ml	5878
Worthington	5887
calcium-free complete saline solution with trace cysteine	5903
calcium-free complete saline solution	5903
trace cysteine	5946
37 °C on a rotary shaker in a CO2 incubator	5964
37 °C	5964
a rotary shaker in a CO2 incubator	5973
a rotary shaker	5973
a CO2 incubator	5992
Tissue	6009
very gentle mechanical trituration	6042
a culture flask for 1 h in DMEMwith	6100
a culture flask	6100
1 h in DMEMwith	6120
1 h	6120
DMEMwith	6127
10 % FCS before removing and washing nonadherent cells	6136
10 % FCS	6136
nonadherent cells	6173
All cells	6192
three times	6214
DMEMonly	6229
30,000 cells per microliter	6262
30,000 cells	6262
microliter	6279
identification	6295
the isolated cells	6311
poly-L-lysine coated chamber slides	6356
DMEM	6408
10 % FCS and penicillin/streptomycin	6418
5 -- 7 days	6462
5	6462
7 days	6464
the cells	6472
ice-cold methanol	6498
rabbit anti-p75 -LRB- Chemicon Temecula , USA -RRB- and mouse anti-S-100 -LRB- Chemicon Temecula , USA -RRB-	6533
rabbit anti-p75	6533
Chemicon Temecula	6550
USA	6569
mouse anti-S-100	6578
Chemicon Temecula	6596
USA	6615
primary antibodies	6620
Alexiflour 488 goat anti-mouse -LRB- 1:1,000 , Molecular Probes , USA -RRB- and 594 goat anti-rabbit -LRB- 1:1,000 , Molecular Probes , USA -RRB- secondary antibodies	6656
Alexiflour 488 goat anti-mouse -LRB- 1:1,000 , Molecular Probes , USA -RRB-	6656
Alexiflour 488 goat anti-mouse	6656
Alexiflour	6656
488 goat	6667
1:1,000	6688
Molecular Probes	6697
USA	6715
594 goat anti-rabbit -LRB- 1:1,000 , Molecular Probes , USA -RRB- secondary antibodies	6724
594 goat	6724
1:1,000 , Molecular Probes , USA	6746
1:1,000	6746
Molecular Probes	6755
USA	6773
Hoechst 33358 -LRB- 1:1,000 , Molecular Probes , USA -RRB- nuclear stain	6824
Hoechst 33358 -LRB- 1:1,000 , Molecular Probes , USA -RRB-	6824
Hoechst 33358	6824
1:1,000	6839
Molecular Probes	6848
USA	6866
nuclear	6871
Antibody staining	6886
at least 95 % of donor cells	6929
at least 95 %	6929
donor cells	6946
P75 and S-100 positive	6968
P75 and S-100	6968
Contusion Injury Adult male Sprague -- Dawley -LRB- SD -RRB- rats -LRB- 200 -- 250 g -RRB- were housed according to the Third Military Medical University -LRB- TMMU -RRB- guidelines , and surgical procedures and post-op care	6992
Contusion Injury Adult male Sprague	6992
Dawley -LRB- SD -RRB- rats -LRB- 200 -- 250 g -RRB- were housed according to the Third Military Medical University -LRB- TMMU -RRB- guidelines , and surgical procedures and post-op care	7028
Dawley	7028
SD	7036
rats -LRB- 200 -- 250 g -RRB-	7040
rats	7040
200 -- 250 g	7046
200	7046
250 g	7050
the Third Military Medical University -LRB- TMMU -RRB- guidelines , and surgical procedures and post-op care	7082
the Third Military Medical University -LRB- TMMU -RRB- guidelines	7082
TMMU	7121
surgical procedures and post-op care	7143
surgical procedures	7143
post-op care	7167
accordance	7198
protocols approved by TMMU Institutional Animal Care and Use Committee	7214
protocols	7214
TMMU Institutional Animal Care and Use Committee	7236
Rats	7286
a single intraperitoneal injection of 3 % sodium pentobarbiturate -LRB- 40 -- 50 mg/kg -RRB-	7314
a single intraperitoneal injection	7314
3 % sodium pentobarbiturate -LRB- 40 -- 50 mg/kg -RRB-	7352
3 % sodium pentobarbiturate	7352
40 -- 50 mg/kg	7381
40	7381
50 mg/kg	7384
a sterile laminectomy	7399
vertebral levels T10	7438
the dura	7478
The spinal cords	7488
an NYU-II impactor	7525
a dropping weight -LRB- 10.0 g -RRB- from 25mmabove	7549
a dropping weight -LRB- 10.0 g -RRB-	7549
a dropping weight	7549
10.0 g	7568
25mmabove	7581
the exposed cord -LRB- Basso et al. 1996 -RRB-	7591
the exposed cord	7591
Basso	7609
et al. 1996	7615
et al.	7615
1996	7622
injury	7635
the muscles and skin	7643
the muscles	7643
skin	7659
layers	7679
The procedure	7687
hind limb paralysis	7713
all animals	7736
wound and bladder infections	7760
Bicillin -LRB- 60,000 U/kg , i.m. -RRB-	7790
Bicillin	7790
60,000 U/kg , i.m.	7800
60,000 U/kg	7800
i.m.	7813
7 days	7839
bladder expression performed twice daily for 7 days after contusion	7851
bladder expression	7851
7 days	7896
contusion	7909
Transplantation of SCs and OECs Seven days after the initial surgery , the rats	7920
Transplantation	7920
SCs and OECs Seven days after the initial surgery , the rats	7939
SCs and OECs	7939
Seven days	7952
the initial surgery , the rats	7969
the initial surgery	7969
the rats	7990
the cords	8023
the same site	8052
One microliter cell suspension	8067
the midline of the contused cord at a depth of 0.8 mm at the epicenter of the lesion	8117
the midline	8117
the contused cord at a depth of 0.8 mm at the epicenter of the lesion	8132
the	8132
cord	8145
a depth of 0.8 mm	8153
a depth	8153
0.8 mm	8164
the epicenter of the lesion	8174
the epicenter	8174
the lesion	8191
1 mm rostral and caudal to the epicenter	8210
1 mm rostral	8210
caudal to the epicenter	8227
caudal	8227
the epicenter	8237
a total of 3 μl of cell suspension	8252
a total	8252
3 μl of cell suspension	8263
3 μl	8263
cell suspension	8271
The cell injections	8297
a drawn glass micropipette , which remained in place for 5 min after each injection	8338
a drawn glass micropipette	8338
place for 5 min	8384
place	8384
5 min	8394
each injection	8406
The control animals	8422
identical volumes of DMEM	8459
identical volumes	8459
DMEM	8480
the same sites	8488
the injection	8510
the muscle and skin	8525
interrupted sutures	8562
The survival time of the animals	8583
The survival time	8583
the animals	8604
3 weeks -LRB- n015 -RRB- and 6 weeks -LRB- n015 -RRB-	8620
3 weeks -LRB- n015 -RRB-	8620
n015	8629
6 weeks -LRB- n015 -RRB-	8639
n015	8648
Histological Procedures and Semi-Quantification	8655
Histological Procedures	8655
Semi-Quantification	8683
3 and 6 weeks after transplantation	8706
3 and 6 weeks	8706
transplantation	8726
the host rats	8743
physiological saline , followed by 4 % paraformaldehyde for frozen sectioning or 2 % paraformaldehyde and 2 % glutaraldehyde in PBS -LRB- pH 7.4 -RRB- for plastic sectioning	8791
physiological saline	8791
4 % paraformaldehyde for frozen sectioning or 2 % paraformaldehyde and 2 % glutaraldehyde	8825
4 % paraformaldehyde for frozen sectioning	8825
4 % paraformaldehyde	8825
frozen sectioning	8850
2 % paraformaldehyde and 2 % glutaraldehyde	8871
2 % paraformaldehyde	8871
2 % glutaraldehyde	8896
PBS -LRB- pH 7.4 -RRB- for plastic sectioning	8918
PBS -LRB- pH 7.4 -RRB-	8918
PBS	8918
pH 7.4	8923
plastic sectioning	8935
the spinal cords	8961
4 % paraformaldehyde for frozen sections or 3 % glutaraldehyde for plastic sections	9009
4 % paraformaldehyde for frozen sections	9009
4 % paraformaldehyde	9009
frozen sections	9032
3 % glutaraldehyde for plastic sections	9051
3 % glutaraldehyde	9051
plastic sections	9073
Frozen longitudinal serial sections of the spinal cords	9091
Frozen longitudinal serial sections	9091
the spinal cords	9130
a thickness of 15 μm on a LEICA Cryostat	9159
a thickness	9159
15 μm on a LEICA Cryostat	9174
15 μm	9174
a LEICA Cryostat	9183
a heating plate	9210
Aqua Poly / Mount -LRB- Polyscience , Inc. -RRB-	9243
Aqua Poly / Mount	9243
Aqua Poly	9243
Mount	9254
Polyscience	9261
Inc.	9274
The sections	9281
Olympus fluorescence microscope	9314
DP71 digital camera and software	9368
DP71 digital camera	9368
software	9392
All lesions	9402
both FITC and Rodamine excitation wavelengths	9431
FITC	9436
Rodamine excitation wavelengths	9445
transplanted SCs and OECs which fluoresce only in the green wavelength	9500
transplanted SCs and OECs	9500
the green wavelength	9550
macrophages autoflouresce	9577
all wavelengths	9606
The digital images	9623
20 ×	9660
Adobe Phostoshop 10.0	9682
measurements of cell distribution	9718
measurements	9718
cell distribution	9734
duplication	9760
Spot 345 software	9773
Spot	9773
345 software	9778
the distribution and migration of SCs and OECs	9811
the distribution and migration	9811
SCs and OECs	9845
the contused cord	9861
the	9861
cord	9874
Plastic coronal semi-thin sections -LRB- 1 um -RRB-	9880
Plastic coronal semi-thin sections	9880
1 um	9916
tissue blocks	9978
Sections	9993
methylene blue/Azure II	10020
the lesion and location under Olympus BX50 microscope	10061
the lesion and location	10061
Olympus BX50 microscope	10091
ultra-thin sections -LRB- 0.6 μm -RRB-	10121
ultra-thin sections	10121
0.6 μm	10142
the tissue blocks embedded plastically	10164
the tissue	10164
uranyl	10224
salts	10240
a TECNT 10 electron microscope -LRB- Netherlands -RRB-	10265
a TECNT 10 electron microscope	10265
Netherlands	10297
Immunohistochemistry of GFAP and Neurofilament and Semi-Quantification Longitudinal cryo-sections	10311
Immunohistochemistry	10311
GFAP and Neurofilament and Semi-Quantification Longitudinal cryo-sections	10335
PBS for 30 min	10424
PBS	10424
30 min	10432
solution -LRB- PBS , 1 % BSA , 0.3 % Triton X-100 , 5 % normal goat serum -RRB- for 1 h at room temperature	10467
solution	10467
PBS , 1 % BSA , 0.3 % Triton X-100 , 5 % normal goat serum	10477
PBS	10477
1 % BSA , 0.3 % Triton X-100 , 5 % normal goat serum	10482
1 % BSA	10482
0.3 % Triton X-100	10491
5 % normal goat serum	10511
1 h at room temperature	10538
1 h	10538
room temperature	10545
the sections	10569
the primary antibodies of mouse anti-GFAP monoclonal antibody -LRB- 1:200 , Sigma , Saint Louis , USA -RRB- and mouse anti-NF monoclonal antibody -LRB- 1:200 ; Chemicon Inc. , Temecula , CA , USA -RRB-	10602
the primary antibodies	10602
mouse anti-GFAP monoclonal antibody -LRB- 1:200 , Sigma , Saint Louis , USA -RRB- and mouse anti-NF monoclonal antibody -LRB- 1:200 ; Chemicon Inc. , Temecula , CA , USA -RRB-	10628
mouse anti-GFAP monoclonal antibody	10628
1:200 , Sigma , Saint Louis , USA	10665
1:200	10665
Sigma	10672
Saint Louis	10679
USA	10692
mouse anti-NF monoclonal antibody	10701
1:200 ; Chemicon Inc. , Temecula , CA , USA	10736
1:200	10736
Chemicon Inc. , Temecula , CA , USA	10743
1 h at room temperature and 24 h at 4 °C	10781
1 h at room temperature	10781
1 h	10781
room temperature	10788
24 h at 4 °C	10809
24 h	10809
4 °C	10817
several times	10830
PBS	10849
the red fluorescent-conjugated secondary antibody -LRB- goat antimouse IgG , 1:200 , Sigma , Saint Louis , USA -RRB- for 2 h	10873
the red fluorescent-conjugated secondary antibody -LRB- goat antimouse IgG , 1:200 , Sigma , Saint Louis , USA -RRB-	10873
the red fluorescent-conjugated secondary antibody	10873
goat antimouse IgG , 1:200 , Sigma , Saint Louis , USA	10924
goat antimouse IgG	10924
1:200	10944
Sigma	10950
Saint Louis	10957
USA	10970
2 h	10979
room temperature	10986
the sections	11013
Aqua Poly/Mount -LRB- Polyscience , Warrington , PA , USA -RRB-	11066
Aqua Poly/Mount	11066
Polyscience , Warrington	11083
PA	11108
USA	11112
Control sections	11118
the test batch	11169
the primary antibody	11190
sections	11237
Olympus	11281
BX50 light microscope	11289
BX50	11289
microscope	11300
Images	11312
a DP71CCD camera/software	11339
Adobe Photoshop 10.0	11381
the measurement of the areas of GFAP and NF	11407
the measurement	11407
the areas of GFAP and NF	11426
the areas	11426
GFAP and NF	11439
injured area containing both transplanted cells and GFAP or NF reaction	11452
injured area	11452
transplanted cells and GFAP or NF reaction	11481
transplanted cells	11481
GFAP or NF reaction	11504
20 × -LRB- 0.388 mm2 -RRB-	11545
20 ×	11545
0.388 mm2	11550
every fifth section	11566
a total of five sections from each animal	11591
a total	11591
five sections from each animal	11602
five sections	11602
each animal	11621
The proportion of the GFAP and NF positive areas within the field	11634
The proportion	11634
the GFAP and NF positive areas within the field	11652
the GFAP	11652
NF positive areas within the field	11665
NF positive areas	11665
the field	11690
a percentage of the field	11732
a percentage	11732
the field	11748
Behavioral Testing Using the BBB locomotor rating scale -LRB- Basso et al. 1995 -RRB- , all rats were tested for locomotor function by two observers	11759
Behavioral	11759
the BBB locomotor rating scale -LRB- Basso et al. 1995 -RRB- , all rats were tested for locomotor function by two observers	11784
the BBB locomotor rating scale	11784
Basso	11816
et al. 1995	11822
et al.	11822
1995	11829
all rats	11836
locomotor function	11861
two observers	11883
the treatment groups	11908
BBB testing	11930
1 week	11974
6 weeks	12022
CSEP Recording and Analysis	12052
6 weeks	12083
transplantation	12097
15 rats -LRB- n05 in each group -RRB-	12114
15 rats	12114
n05 in each group	12123
n05	12123
each group	12130
3 % sodium pentobarbiturate , fixed stereotaxically , and injected with atropine sulfate -LRB- 0.8 mg/kg -RRB- for reducing tracheal secretions	12165
3 % sodium pentobarbiturate	12165
atropine sulfate -LRB- 0.8 mg/kg -RRB-	12235
atropine sulfate	12235
0.8 mg/kg	12253
tracheal secretions	12277
Both left and right sciatic nerves	12298
a bipolar platinum wire electrode with positive current pulses of 10 mA magnitude , 0.25 ms duration , and 1 Hz frequency	12368
a bipolar platinum wire electrode with positive current pulses of 10 mA magnitude	12368
a bipolar platinum wire electrode	12368
positive current pulses of 10 mA magnitude	12407
positive current pulses	12407
10 mA magnitude	12434
0.25 ms duration	12451
0.25 ms	12451
duration	12459
1 Hz frequency	12473
CSEP	12489
a Neuropack -LRB- Nihon Kohden Co , Japan -RRB- with a monopolar silver-ball placed on the surface of the sensorimotor cortex -LRB- bregma − 2 mm , lateral 2 mm -RRB-	12515
a Neuropack -LRB- Nihon Kohden Co , Japan -RRB-	12515
a Neuropack	12515
Nihon Kohden Co	12528
Japan	12545
a monopolar silver-ball placed on the surface of the sensorimotor cortex	12557
a monopolar silver-ball	12557
the surface of the sensorimotor cortex	12591
the surface	12591
the sensorimotor cortex	12606
bregma − 2 mm , lateral 2 mm	12631
bregma −	12631
2 mm , lateral 2 mm	12639
2 mm	12639
lateral 2 mm	12644
2	12652
The effect of electrical stimulation on CSEP	12658
The effect	12658
electrical stimulation on CSEP	12672
electrical stimulation	12672
CSEP	12698
terms of latency , the time elapsing between a stimulus and the response to it -LRB- millisecond -RRB- and amplitude and voltage from the wave top to the bottom -LRB- millivolt -RRB-	12719
terms	12719
latency , the time elapsing between a stimulus and the response to it -LRB- millisecond -RRB- and amplitude and voltage from the wave top to the bottom -LRB- millivolt -RRB-	12728
latency	12728
the time elapsing between a stimulus and the response to it -LRB- millisecond -RRB- and amplitude and voltage from the wave top to the bottom -LRB- millivolt -RRB-	12737
the time	12737
a stimulus and the response	12763
a stimulus	12763
the response	12778
it -LRB- millisecond -RRB- and amplitude and voltage from the wave top	12794
it -LRB- millisecond -RRB-	12794
it	12794
amplitude and voltage from the wave top	12815
amplitude and voltage	12815
the wave top	12842
the bottom -LRB- millivolt -RRB-	12858
the bottom	12858
millivolt	12870
potentials	12906
all subjects	12920
the spinal cords	12934
histological processing	12968
Statistical Analysis Comparison of the migration and distribution of transplanted cells between the groups	12993
Statistical Analysis Comparison	12993
the migration and distribution of transplanted cells between the groups	13028
the migration and distribution	13028
transplanted cells between the groups	13062
transplanted cells	13062
the groups	13089
two-tailed Student 's t test	13120
two-tailed Student 's	13120
Mann -- Whitney test was applied to analyze the areas of GFAP and NF .	13149
Mann	13149
Whitney test	13154
the areas of GFAP and NF	13190
the areas	13190
GFAP and NF	13203
P values	13216
three digits and less than 0.05 regarded as significant	13241
three digits	13241
less than 0.05 regarded as significant	13258
less than 0.05	13258
the values between groups	13318
the values	13318
groups	13337
the standard error -LRB- SEM -RRB-	13345
the standard error	13345
SEM	13365
± value in the text	13402
± value	13402
the text	13412
SEM bars on graphs	13428
SEM bars	13428
graphs	13440
Results	13449
1 Histological observation of SCs and OECs transplanted to the contused spinal cord	13463
1 Histological observation	13463
SCs and OECs transplanted to the contused spinal cord	13493
SCs and OECs	13493
the contused spinal cord	13522
the	13522
spinal cord	13535
SCs transplantation	13554
the myelinated axons	13575
groups	13603
light microscope -LRB- a -RRB-	13616
light microscope	13616
electron microscope	13644
the clusters of myelinated axons and SCs	13665
the clusters	13665
myelinated axons and SCs	13681
thin glial membrane -LRB- arrows -RRB-	13724
thin glial membrane	13724
arrows	13745
some hypertrophic astrocytes -LRB- c -RRB-	13771
some hypertrophic astrocytes	13771
c	13801
the cord	13808
OECs	13827
the myelinated axons	13833
the spinal cord tissue	13881
astrocytes	13908
heperplasia and hypertrophy	13935
light and electron microscope -LRB- b , d -RRB-	13969
light and electron microscope	13969
c A astrocyte , S Schwann cell , M myelinated axon .	14007
c A astrocyte , S Schwann cell	14007
M myelinated axon	14038
M	14038
axon	14051
Scale bar : a , b010 μm ; c , d02 μm Fig. 2 Immunoreaction of GFAP after SCs and OECs transplantion .	14057
Scale bar	14057
a , b010 μm ; c , d02 μm Fig. 2 Immunoreaction of GFAP after SCs and OECs transplantion	14068
a , b010 μm ; c , d02 μm	14068
b010 μm ; c	14071
b010 μm	14071
c	14080
Fig. 2 Immunoreaction of GFAP after SCs and OECs transplantion	14091
Fig. 2 Immunoreaction	14091
GFAP after SCs and OECs transplantion	14116
GFAP	14116
SCs and OECs transplantion	14127
the cord	14158
SCs	14177
GFAP expression	14182
a distinct astroglial border	14227
many branches penetrating into the injured area -LRB- a -RRB-	14261
many branches	14261
the injured area -LRB- a -RRB-	14292
the injured area	14292
the cord	14317
OECs	14336
astroglial prominences	14342
astroglial border	14380
b	14411
OECs	14420
astroglial tissue	14441
they	14460
-LRB- b1 -RRB- , but not SCs -LRB- a1 -RRB-	14482
-LRB- b1 -RRB-	14482
SCs -LRB- a1 -RRB-	14496
SCs	14496
a1	14501
Scale	14506
a , b00 .15 mm ; a1 , b1050	14517
b00 .15 mm ; a1	14520
b00 .15 mm	14520
a1	14531
μm Fig. 3 Percentage of GFAP area after SCs and OECs transplantation , which was significantly higher in SCs injection than OECs injection	14541
μm Fig.	14541
3 Percentage	14550
GFAP area after SCs and OECs transplantation , which was significantly higher in SCs injection than OECs injection	14566
GFAP area	14566
SCs and OECs transplantation	14582
SCs injection	14646
OECs injection	14665
p <	14682
p	14682
<	14683
0.05 compared with 3 weeks , + p < 0.05 compared between the groups Fig. 4 The distribution and migration of SCs and OECs in the contused spinal cord .	14685
0.05	14685
3 weeks , + p	14704
3 weeks	14704
p	14714
the groups	14738
4	14755
The distribution and migration of SCs and OECs in the contused spinal cord	14757
The distribution and migration	14757
SCs and OECs in the contused spinal cord	14791
SCs and OECs	14791
the contused spinal cord	14807
the	14807
spinal cord	14820
SCs	14833
a shorter migration distance in the injured area	14864
a shorter migration distance	14864
the injured area	14896
that of OECs , which could migrated into the normal tissue near to the injured area -LRB- b -RRB-	14922
that	14922
OECs , which could migrated into the normal tissue near to the injured area -LRB- b -RRB-	14930
OECs	14930
the normal tissue	14962
the injured area	14988
b	15006
distribution and migration of OECs	15030
distribution and migration	15030
OECs	15060
that of SCs -LRB- c , d -RRB-	15105
that	15105
SCs -LRB- c , d -RRB-	15113
SCs	15113
Scale bar : a , b00 .15 mm .	15125
Scale bar	15125
a , b00 .15 mm	15136
a	15136
b00 .15 mm	15139
p <	15151
p	15151
<	15152
0.05 compared with 3 weeks , + p <	15153
0.05	15153
3 weeks , + p <	15172
3 weeks	15172
p <	15182
p	15182
the groups	15206
5 Immunoreaction of NF	15223
5 Immunoreaction	15223
NF	15243
SCs and OECs transplantion	15252
Both donor cells	15280
the axons labeled by NF immunoreaction	15310
the axons	15310
NF immunoreaction	15331
the injured area	15366
NF immunoreactive axons	15403
number and thicker in diameter in OECs group -LRB- b -RRB-	15439
number	15439
thicker in diameter in OECs group -LRB- b -RRB-	15450
thicker	15450
diameter in OECs group -LRB- b -RRB-	15461
diameter in OECs group	15461
OECs	15473
b	15485
SCs group	15496
-LRB- a -RRB- , which is further showed by the enlargers -LRB- c , d -RRB-	15506
-LRB- a -RRB- , which is further showed by the enlargers	15506
the enlargers	15538
Scale bar : a , b0200 μm ; c , d030 μm Fig. 6 Percentage of NF area after SCs and OECs transplantation .	15560
Scale bar	15560
a , b0200 μm ; c , d030 μm Fig. 6 Percentage of NF area after SCs and OECs transplantation	15571
a , b0200 μm ; c , d030 μm	15571
b0200 μm ; c	15574
b0200 μm	15574
c	15584
Fig. 6 Percentage of NF area after SCs and OECs transplantation	15596
Fig. 6 Percentage	15596
NF area after SCs and OECs transplantation	15617
NF area	15617
SCs and OECs transplantation	15631
it	15670
SCs group	15688
OECs group	15706
no significant differences between the groups	15718
no significant differences	15718
the groups	15753
the statistical analysis	15780
p < 0.05 compared with 3 weeks Fig. 7 BBB scores and CSEP after SCs and OECs transplantation .	15807
p	15807
3 weeks Fig.	15828
7 BBB scores and CSEP after SCs and OECs transplantation	15842
7 BBB scores and CSEP	15842
SCs and OECs transplantation	15870
Both SCs and OECs	15900
locomotor function	15932
the 6-week recovery period	15958
toDMEM	15994
CSEP	16005
cell-inject groups	16036
the sixth week	16058
transplantation -LRB- b -RRB-	16079
transplantation	16079
b	16096
the amplitude	16104
the latency	16136
the normal group	16174
they	16201
DMEM group -LRB- c , d -RRB-	16246
DMEM group	16246
p	16266
0.01 compared with the control -LRB- DMEM -RRB- group , + p < 0.01	16268
0.01	16268
the control -LRB- DMEM -RRB- group , + p < 0.01	16287
the control -LRB- DMEM -RRB- group	16287
the control	16287
DMEM	16300
group	16306
p < 0.01	16314
p <	16314
p	16314
0.01	16316
normal group SCs Differ	16335
OECs on the Reaction of Astrocytes in Morphology Following the injection of SCs and OECs	16365
OECs	16365
the Reaction of Astrocytes in Morphology Following the injection of SCs and OECs	16373
the Reaction	16373
Astrocytes in Morphology Following the injection of SCs and OECs	16389
Astrocytes	16389
Morphology Following the injection of SCs and OECs	16403
Morphology	16403
the injection of SCs and OECs	16424
the injection	16424
SCs and OECs	16441
the contused spinal cord at the T10 spinal level	16459
the	16459
spinal cord	16472
the T10 spinal level	16487
the astrocytes	16509
different extent	16542
the transplanted cells	16562
the cords	16592
SCs	16611
the astrocytes	16616
larger	16655
their cell body	16665
the myelinated axons	16687
groups	16728
the glial membrane -LRB- Fig. 1a -RRB-	16738
the glial membrane	16738
Fig. 1a	16758
These features	16768
the ultrastructural level , which clusters of SCs were enveloped by a thin glial membrane and myelinated axons were surrounded by some hypertrophic astrocytes -LRB- Fig. 1c -RRB-	16812
the ultrastructural level	16812
clusters of SCs	16845
clusters	16845
SCs	16857
a thin glial membrane	16879
myelinated axons	16905
some hypertrophic astrocytes -LRB- Fig. 1c -RRB-	16941
some hypertrophic astrocytes	16941
Fig. 1c	16971
contrast with SCs transplantation	16984
contrast	16984
SCs transplantation	16998
a number of mylinated axons	17029
a number	17029
mylinated axons	17041
both light and electron microscopes	17072
OECs	17109
hyperplasia and hypertrophy of astrocytes	17131
hyperplasia and hypertrophy	17131
astrocytes	17162
a plenty of glial tissue -LRB- Fig. 1b , d -RRB-	17187
a plenty	17187
glial tissue -LRB- Fig. 1b , d -RRB-	17199
glial tissue	17199
Fig. 1b , d	17213
Fig. 1b	17213
d	17222
SCs	17226
More Enhanced GFAP Immunoreactivity than OECs Do In order to assess the host astrocytes response following the injections of SCs and OECs , cryostat sections were immunostained for GFAP , a reliable marker widely used for detecting astrocytic responses to injury	17237
More	17237
GFAP Immunoreactivity	17251
OECs	17278
the host astrocytes response following the injections of SCs and OECs	17305
the host astrocytes response	17305
the injections of SCs and OECs	17344
the injections	17344
SCs and OECs	17362
cryostat sections	17376
GFAP , a reliable marker widely used for detecting astrocytic responses to injury	17417
GFAP	17417
a reliable marker widely used for detecting astrocytic responses to injury	17423
a reliable marker	17423
astrocytic responses	17467
injury	17491
It	17499
more enhanced GFAP expression	17519
more	17519
GFAP expression	17533
SCs injection	17568
a distinct astroglial border	17591
many prominences or branches penetrating into the injured area	17625
many prominences or branches	17625
the injured area	17671
a blurred astroglial border with fewer penetrations after OECs injection -LRB- Fig. 2a , b -RRB-	17701
a blurred astroglial border	17701
fewer penetrations after OECs injection -LRB- Fig. 2a , b -RRB-	17734
fewer penetrations	17734
OECs injection -LRB- Fig. 2a , b -RRB-	17759
OECs injection	17759
Fig. 2a , b	17775
Fig. 2a	17775
b	17784
OECs	17803
astroglial tissue while SCs can not -LRB- Fig. 2a1 , b1 -RRB-	17833
astroglial tissue	17833
SCs	17857
Fig. 2a1 , b1	17869
Fig. 2a1	17869
b1	17879
the area of GFAP immunoreactivity	17896
the area	17896
GFAP immunoreactivity	17908
SCs injection	17950
there	17965
GFAP areas of 23.71 % and 28.24 % at 3 and 6 weeks	17976
GFAP areas of 23.71 %	17976
GFAP areas	17976
23.71 %	17990
28.24 % at 3 and 6 weeks	18002
28.24 %	18002
at 3 and 6 weeks	18010
more than 17.76 % and 24.53 % after OECs injection -LRB- p < 0.05 -RRB- -LRB- Fig. 3 -RRB-	18042
more than 17.76 %	18042
24.53 % after OECs injection -LRB- p < 0.05 -RRB- -LRB- Fig. 3 -RRB-	18064
24.53 %	18064
OECs injection -LRB- p < 0.05 -RRB- -LRB- Fig. 3 -RRB-	18078
OECs injection -LRB- p < 0.05 -RRB-	18078
OECs injection	18078
p < 0.05	18094
p	18094
< 0.05	18095
<	18095
0.05	18096
Fig. 3	18103
The Distribution and Migration Differ Following SCs and OECs Transplantation The distribution and migration of SCs and OECs	18112
The Distribution	18112
Migration Differ Following SCs and OECs Transplantation The distribution and migration of SCs and OECs	18133
Migration Differ	18133
SCs and OECs Transplantation The distribution and migration of SCs and OECs	18160
SCs and OECs Transplantation The distribution	18160
SCs and OECs	18160
The distribution	18189
migration of SCs and OECs	18210
migration	18210
SCs and OECs	18223
3 and 6 weeks following transplantation	18253
3 and 6 weeks	18253
transplantation	18277
Both donor cells	18294
the injured area at 3 weeks -LRB- Fig. 4a , b -RRB-	18339
the injured area	18339
3 weeks -LRB- Fig. 4a , b -RRB-	18359
3 weeks	18359
Fig. 4a , b	18368
Fig. 4a	18368
b	18377
6 weeks -LRB- Fig. 5a , b -RRB-	18401
6 weeks	18401
Fig. 5a , b	18410
Fig. 5a	18410
b	18419
the distribution of SCs	18432
the distribution	18432
SCs	18452
that of OECs in the contused spinal cord	18483
that	18483
OECs in the contused spinal cord	18491
OECs	18491
the contused spinal cord	18499
the	18499
spinal cord	18512
both donor cells	18535
the cord	18584
SCs	18598
shorter distance	18611
the normal tissue	18655
OECs	18686
distance	18712
a few cells	18725
the normal tissue	18751
Quantification of the distribution and migration	18770
Quantification	18770
the distribution and migration	18788
3 weeks	18834
the area of the distribution	18843
the area	18843
the distribution	18855
1.51 ± 0.45 mm2	18876
1.51	18876
0.45 mm2	18881
a distance of 3.23 ±	18895
a distance	18895
3.23 ±	18909
0.53 mm in the SCs group , which was significantly different from 1.82 ± 0.38 mm2 with a distance of 4.91 ± 0.58 mm in the OECs group -LRB- p < 0.05 -RRB-	18914
0.53 mm	18914
the SCs group , which was significantly different from 1.82 ± 0.38 mm2 with a distance of 4.91 ± 0.58 mm in the OECs group -LRB- p < 0.05 -RRB-	18925
the SCs group	18925
1.82 ±	18979
0.38 mm2 with a distance of 4.91 ± 0.58 mm	18984
0.38 mm2	18984
a distance of 4.91 ± 0.58 mm	18998
a distance	18998
4.91 ± 0.58 mm	19012
4.91 ±	19012
0.58 mm	19018
the OECs group -LRB- p < 0.05 -RRB-	19029
the OECs group	19029
p < 0.05	19045
p	19045
< 0.05	19046
<	19046
0.05	19047
the animals	19059
the cells	19082
the parameters	19137
1.99 ±	19165
0.49 mm2 with a distance of 5.23 ± 0.51 mm in the SCs group and 2.73 ± 0.53 mm2	19170
0.49 mm2 with a distance of 5.23 ± 0.51 mm	19170
0.49 mm2	19170
a distance of 5.23 ± 0.51	19184
a distance	19184
5.23 ± 0.51	19198
the SCs group and 2.73	19214
the SCs group	19214
2.73	19232
0.53 mm2	19237
a distance of 6.43 ±	19251
a distance	19251
6.43 ±	19265
0.43 mm in the OECs group	19270
0.43 mm	19270
the OECs group	19281
the sixth week	19299
the difference	19335
significant -LRB- p < 0.05 -RRB- -LRB- Fig. 4c , d -RRB-	19354
significant -LRB- p < 0.05 -RRB-	19354
significant	19354
p < 0.05	19367
p	19367
< 0.05	19368
<	19368
0.05	19369
Fig. 4c , d	19376
Fig. 4c	19376
d	19385
SCs and OECs	19389
Similar Changes	19409
NF Immunoreactivity	19428
At 3 and 6 weeks	19448
cell injection , both SCs and OECs	19471
cell injection	19471
both SCs	19487
OECs	19500
morphologies	19537
the axons labeled by the NF immunoreaction to grow toward to the injured area	19564
the axons	19564
the NF immunoreaction	19585
the injured area	19625
Most of the regenerating axons	19643
Most	19643
the regenerating axons	19651
the main axis of projecting axons , while a few donor cells intercrossed with the axons -LRB- Fig. 5a -- d -RRB-	19714
the main axis	19714
axons , while a few donor cells intercrossed with the axons -LRB- Fig. 5a -- d -RRB-	19742
axons	19742
a few donor cells	19755
the axons -LRB- Fig. 5a -- d -RRB-	19791
the axons	19791
Fig. 5a -- d	19802
Fig. 5a	19802
d	19810
Qualitative observation	19814
the number of NF immunoreactive axons	19850
the number	19850
NF immunoreactive axons	19864
the OECs group	19900
the SCs group , which was confirmed by quantifying the area of NF immunoreactivity	19923
the SCs group	19923
the area of NF immunoreactivity	19973
the area	19973
NF immunoreactivity	19985
a percentage of 10.46 % and 14.74 % in the SCs receiving animals and 11.55 % and 16.23 % in the OECs receiving animals at 3 and 6 weeks , respectively	20014
a percentage	20014
10.46 % and 14.74 % in the SCs receiving animals and 11.55 % and 16.23 % in the OECs receiving animals at 3 and 6 weeks , respectively	20030
10.46 % and 14.74 % in the SCs receiving animals	20030
10.46 % and 14.74 %	20030
the SCs	20053
animals	20071
11.55 % and 16.23 % in the OECs receiving animals at 3 and 6 weeks , respectively	20083
11.55 % and 16.23 %	20083
the OECs	20106
animals	20125
3 and 6 weeks , respectively	20136
3 and 6 weeks	20136
the area of NF	20174
the area	20174
NF	20186
6 weeks than at 3 weeks	20203
6 weeks	20203
each group	20234
no significant differences between the groups	20246
no significant differences	20246
the groups	20281
the statistical analysis -LRB- Fig. 6 -RRB-	20309
the statistical analysis	20309
Fig. 6	20335
SCs and OECs	20344
Locomotor Performance and CSEP of the Transplanted Rats All animals	20365
Locomotor Performance and CSEP	20365
the Transplanted Rats All animals	20399
gradual improvements	20443
hind limb locomotor function	20467
the 6-week recovery period	20503
One week	20531
transplantation , BBB scores for SCs and OECs	20546
transplantation	20546
BBB scores for SCs and OECs	20563
BBB scores	20563
SCs and OECs	20578
transplanted rats	20591
6.82 ± 1.30 and 7.2 ± 1.27 respectively	20618
6.82 ± 1.30	20618
6.82	20618
1.30	20623
7.2 ± 1.27 respectively	20632
7.2 ±	20632
1.27 respectively	20636
1.27	20636
3.25 ± 1.13 for DMEM injected rats	20667
3.25	20667
± 1.13 for DMEM	20671
± 1.13	20671
DMEM	20681
rats	20695
6 weeks	20704
SCs rats	20713
13.53 ± 1.16 and OECs rats scored 13.68 ± 1.20 , compared to 9.52 ± 0.95 for the DMEM rats	20729
13.53 ±	20729
1.16 and OECs rats	20735
13.68 ±	20761
1.20	20767
9.52 ± 0.95 for the DMEM rats	20785
9.52 ± 0.95	20785
the DMEM rats	20799
No significant difference between the SCs - and OECsinjected rats	20814
No significant difference	20814
the SCs - and OECsinjected rats	20848
the SCs	20848
OECsinjected rats	20861
the BBB scores of both groups	20916
the BBB scores	20916
both groups	20934
the controls -LRB- p < 0.01 -RRB- -LRB- Fig. 7a -RRB-	20974
the controls -LRB- p < 0.01 -RRB-	20974
the controls	20974
p < 0.01	20988
p	20988
< 0.01	20989
<	20989
0.01	20990
Fig. 7a	20997
CSEP	21007
the end of the sixth week	21030
the end	21030
the sixth week	21041
transplantation	21062
all the experimental groups -LRB- Fig. 7b -RRB-	21103
all the experimental groups	21103
Fig. 7b	21132
the amplitude	21150
the latency	21182
the three injected groups compared to the normal group with the amplitude of 1.37 ± 0.16 mV and the latency of 6.05 ± 0.32 ms , which was significantly higher and shorter than 0.42 ± 0.02 mV and 13.12 ± 0.63 ms in the DMEM group , 0.69 ± 0.05 mV and 9.71 ± 0.57 ms in the SCs group , and 0.71 ± 0.51 mV and 10.06 ± 0.47 ms in the OECs group	21211
the three	21211
groups	21230
the normal group with the amplitude of 1.37 ± 0.16 mV and the latency of 6.05 ± 0.32 ms , which was significantly higher and shorter than 0.42 ± 0.02 mV and 13.12 ± 0.63 ms in the DMEM group , 0.69 ± 0.05 mV and 9.71 ± 0.57 ms in the SCs group	21249
the normal group	21249
the amplitude of 1.37 ± 0.16 mV and the latency of 6.05 ± 0.32 ms , which was significantly higher and shorter than 0.42 ± 0.02 mV and 13.12 ± 0.63 ms in the DMEM group , 0.69 ± 0.05 mV and 9.71 ± 0.57 ms in the SCs group	21271
the amplitude	21271
1.37 ± 0.16 mV and the latency of 6.05 ± 0.32 ms , which was significantly higher and shorter than 0.42 ± 0.02 mV and 13.12 ± 0.63 ms in the DMEM group , 0.69 ± 0.05 mV and 9.71 ± 0.57 ms in the SCs group	21288
1.37 ± 0.16 mV	21288
1.37 ±	21288
0.16 mV	21294
the latency of 6.05 ± 0.32 ms , which was significantly higher and shorter than 0.42 ± 0.02 mV and 13.12 ± 0.63 ms in the DMEM group , 0.69 ± 0.05 mV and 9.71 ± 0.57 ms in the SCs group	21306
the latency	21306
6.05 ± 0.32 ms , which was significantly higher and shorter than 0.42 ± 0.02 mV and 13.12 ± 0.63 ms in the DMEM group , 0.69 ± 0.05 mV and 9.71 ± 0.57 ms in the SCs group	21321
6.05 ± 0.32 ms	21321
0.42 ± 0.02 mV and 13.12 ± 0.63 ms	21383
0.42 ± 0.02 mV	21383
0.42 ±	21383
0.02 mV	21388
13.12 ± 0.63 ms	21400
13.12	21400
0.63 ms	21406
the DMEM group , 0.69 ± 0.05 mV and 9.71 ± 0.57 ms	21417
the DMEM group	21417
0.69 ± 0.05 mV	21433
0.69	21433
0.05 mV	21438
9.71 ± 0.57 ms	21450
9.71	21450
0.57 ms	21455
the SCs group	21466
0.71 ± 0.51 mV and 10.06 ± 0.47 ms	21485
0.71 ± 0.51 mV	21485
0.71	21485
0.51 mV	21490
10.06 ± 0.47 ms	21502
10.06	21502
0.47 ms	21508
the OECs group	21519
the amplitude and the latency in the SCs and OECs groups	21544
the amplitude	21544
the latency in the SCs and OECs groups	21562
the latency	21562
the SCs and OECs groups	21577
the DMEM group -LRB- p < 0.01 -RRB- -LRB- Fig. 7c , d -RRB-	21635
the DMEM group -LRB- p < 0.01 -RRB-	21635
the DMEM group	21635
p < 0.01	21650
p	21650
< 0.01	21651
<	21651
0.01	21652
Fig. 7c , d	21659
Fig. 7c	21659
d	21668
Discussion The environment of the injured CNS	21673
Discussion The environment	21673
the injured CNS	21703
unfavorable for axon regeneration for a multiplicity of reasons , foremost among which is the astrocytic response to injury	21722
unfavorable	21722
axon regeneration for a multiplicity of reasons , foremost among which is the astrocytic response to injury	21738
axon regeneration	21738
a multiplicity of reasons , foremost among which is the astrocytic response to injury	21760
a multiplicity	21760
reasons , foremost among which is the astrocytic response to injury	21778
reasons	21778
foremost among which is the astrocytic response to injury	21787
foremost	21787
the astrocytic response to injury	21811
the astrocytic response	21811
injury	21838
a strategy for promoting axon regeneration with transplanting cells to replace or improve the inhibitory CNS glial environment	21852
a strategy	21852
axon regeneration	21877
cells	21914
the inhibitory CNS glial environment	21942
many animal experiments	21996
The current study	22021
the behavior of SCs and OECs	22062
the behavior	22062
SCs and OECs	22078
astrocytes following implantation into the contused spinal cord	22111
astrocytes	22111
implantation into the contused spinal cord	22132
implantation	22132
the contused spinal cord	22150
the	22150
spinal cord	22163
the function of the injured spinal cord improved by either of SCs or OECs using BBB score and CSEP recording	22189
the function	22189
the injured spinal cord improved by either of SCs or OECs using BBB score and CSEP recording	22205
the injured spinal cord	22205
either of SCs or OECs	22241
either	22241
SCs or OECs	22251
BBB score and CSEP recording	22269
BBB score	22269
CSEP recording	22283
Histological results	22299
the proliferation of astrocytes	22332
the proliferation	22332
astrocytes	22353
larger cell bodies and stronger expression of GFAG	22370
larger cell bodies	22370
stronger expression of GFAG	22393
stronger expression	22393
GFAG	22416
SCs cord	22444
OECs cord	22461
SCs	22485
a shorter distance accompanied by a smaller distribution area than OECs	22498
a shorter distance	22498
a smaller distribution area than OECs	22532
a smaller distribution area	22532
OECs	22565
the contused spinal cord	22577
the	22577
spinal cord	22590
both SCs and OECs	22612
NF positive axons , which are new growing or sprouting axons previously confirmed by GAP-43 immunoreaction -LRB- Andrews and Stelzner 2007 -RRB- to regrow toward to the injured area	22643
NF positive axons	22643
axons previously confirmed by GAP-43 immunoreaction -LRB- Andrews and Stelzner 2007 -RRB- to regrow toward to the injured area	22697
axons	22697
GAP-43 immunoreaction -LRB- Andrews and Stelzner 2007 -RRB-	22727
GAP-43 immunoreaction	22727
Andrews and Stelzner 2007	22750
Andrews	22750
Stelzner 2007	22762
the injured area	22797
Electrophysiological and behavioral results	22815
the grafts of either SCs or OECs	22871
the grafts	22871
either SCs or OECs	22885
the function of the contused spinal cord at 6 weeks after transplantation	22918
the function	22918
the contused spinal cord at 6 weeks after transplantation	22934
the	22934
spinal cord	22947
6 weeks	22962
transplantation	22976
This	22993
accordance with the observation in the photochemical injury spinal cord in which both SCs and OECs has potential for restoration of injured spinal cords	23001
accordance	23001
the observation in the photochemical injury spinal cord	23017
the observation	23017
the photochemical injury spinal cord	23036
both SCs and OECs	23082
SCs	23087
OECs	23095
potential for restoration of injured spinal cords	23104
potential	23104
restoration of injured spinal cords	23118
restoration	23118
injured spinal cords	23133
OECs grafts	23159
superior ability	23176
functional recovery -LRB- Garcia-Alias et al. 2004 -RRB-	23204
functional recovery	23204
Garcia-Alias	23225
et al. 2004	23238
et al.	23238
2004	23245
it	23264
assays	23299
the interactions between astrocytes	23316
the interactions	23316
astrocytes	23341
SCs or OECs	23363
astrocytes and SCs	23376
nonoverlapping domains	23418
astrocytes and OECs	23450
co-culture -LRB- Lakatos et al. 2000 ; Fairless et al. 2005 -RRB-	23492
co-culture	23492
Lakatos	23504
et al. 2000 ; Fairless et al. 2005	23512
et al. 2000 ; Fairless et al.	23512
et al. 2000	23512
et al.	23512
2000	23519
Fairless et al.	23525
Fairless	23525
et al.	23534
2005	23541
Astrocytes	23548
hypertrophy when	23567
hypertrophy	23567
contact with SCs	23587
contact	23587
SCs	23600
OECs	23617
SCs	23623
a poor capacity to migrate within astrocyte-rich areas	23635
astrocyte-rich areas	23669
contrast to SCs	23694
contrast	23694
SCs	23706
OECs	23711
astrocytes	23758
their inherent ability to exist alongside astrocytes within the olfactory system -LRB- Doucette 1993 -RRB-	23785
astrocytes within the olfactory system -LRB- Doucette 1993 -RRB-	23827
astrocytes	23827
the olfactory system -LRB- Doucette 1993 -RRB-	23845
the olfactory system	23845
Doucette 1993	23867
vivo studies	23889
it	23903
SCs	23926
more host astrocyte response and GFAP and chondroitin sulphate proteoglycan -LRB- CSPG -RRB- , an inhibitory molecule of axon regeneration -LRB- Fawcet and Asher 1999 ; Plant et al. 2001 -RRB- , expression than OECs following transplantation into white matter of rat spinal cord -LRB- Lakatos et al. 2000 -RRB-	23937
more host astrocyte response	23937
GFAP and chondroitin sulphate proteoglycan -LRB- CSPG -RRB- , an inhibitory molecule of axon regeneration -LRB- Fawcet and Asher 1999 ; Plant et al. 2001 -RRB- , expression than OECs following transplantation into white matter of rat spinal cord -LRB- Lakatos et al. 2000 -RRB-	23970
GFAP and chondroitin sulphate proteoglycan -LRB- CSPG -RRB-	23970
GFAP and chondroitin sulphate proteoglycan	23970
CSPG	24014
an inhibitory molecule of axon regeneration -LRB- Fawcet and Asher 1999 ; Plant et al. 2001 -RRB-	24021
an inhibitory molecule	24021
axon regeneration	24047
Fawcet and Asher 1999 ; Plant et al. 2001	24066
Fawcet and Asher 1999 ; Plant et al.	24066
Fawcet and Asher 1999	24066
Fawcet	24066
Asher 1999	24077
Plant et al.	24089
Plant	24089
et al.	24095
2001	24102
expression than OECs following transplantation into white matter of rat spinal cord -LRB- Lakatos et al. 2000 -RRB-	24109
expression than OECs following transplantation into white matter of rat spinal cord	24109
expression	24109
OECs following transplantation into white matter of rat spinal cord	24125
OECs	24125
transplantation into white matter of rat spinal cord	24140
transplantation	24140
white matter of rat spinal cord	24161
white matter	24161
rat spinal cord	24177
Lakatos	24194
et al. 2000	24202
et al.	24202
2000	24209
the mechanism of different interactions between SCs and OECs with astrocytes	24229
the mechanism	24229
different interactions between SCs and OECs with astrocytes	24246
different interactions	24246
SCs and OECs with astrocytes	24277
SCs and OECs	24277
astrocytes	24295
assays , which suggests that N-cadherin is involved in the adhesion and migration of SCs and OECs	24348
assays	24348
N-cadherin	24376
the adhesion and migration of SCs and OECs	24402
the adhesion and migration	24402
SCs and OECs	24432
astrocytes -LRB- Wilby et al. 1999 ; Fairless et al. 2005 -RRB-	24466
astrocytes	24466
Wilby	24478
et al. 1999 ; Fairless et al. 2005	24484
et al. 1999 ; Fairless et al.	24484
et al. 1999	24484
et al.	24484
1999	24491
Fairless et al.	24497
Fairless	24497
et al.	24506
2005	24513
N-cadherin , a predominant member of the cadherin family ,	24520
N-cadherin	24520
a predominant member of the cadherin family	24532
a predominant member	24532
the cadherin family	24556
an important role in axonal guidance -LRB- Ranscht 2000 -RRB-	24583
an important role	24583
axonal guidance -LRB- Ranscht 2000 -RRB-	24604
axonal guidance	24604
Ranscht 2000	24621
development	24643
N-cadherin	24656
important roles in neurulation -LRB- Takeichi et al. 1990 -RRB-	24671
important roles	24671
neurulation -LRB- Takeichi et al. 1990 -RRB-	24690
neurulation	24690
Takeichi	24703
et al. 1990	24712
et al.	24712
1990	24719
Cadherins	24726
calciumdependent adhesion molecules that can bind to cadherin molecules on adjacent cells and form adherent junctions between cells -LRB- Wanner and Wood 2002 -RRB-	24740
calciumdependent adhesion molecules	24740
cadherin molecules	24793
adjacent cells	24815
adherent junctions between cells -LRB- Wanner and Wood 2002 -RRB-	24839
adherent junctions	24839
cells -LRB- Wanner and Wood 2002 -RRB-	24866
cells	24866
Wanner and Wood 2002	24873
Wanner	24873
Wood 2002	24884
This peptide	24896
adhesion between cells	24928
adhesion	24928
cells	24945
intracellular signaling cascades to promote neurite outgrowth -LRB- Bixby and Zhang 1990 ; Kiryushko et al. 2004 -RRB- and synaptic plasticity -LRB- Fannon and Colman 1996 ; Uchida et al. 1996 ; Bruses 2000 -RRB-	24978
intracellular signaling cascades to promote neurite outgrowth -LRB- Bixby and Zhang 1990 ; Kiryushko et al. 2004 -RRB-	24978
intracellular signaling cascades	24978
neurite outgrowth	25022
Bixby and Zhang 1990 ; Kiryushko et al. 2004	25041
Bixby and Zhang 1990 ; Kiryushko et al.	25041
Bixby and Zhang 1990	25041
Bixby	25041
Zhang 1990	25051
Kiryushko et al.	25063
Kiryushko	25063
et al.	25073
2004	25080
synaptic plasticity -LRB- Fannon and Colman 1996 ; Uchida et al. 1996 ; Bruses 2000 -RRB-	25090
synaptic plasticity	25090
Fannon and Colman 1996 ; Uchida et al. 1996 ; Bruses 2000	25111
Fannon and Colman 1996	25111
Fannon	25111
Colman 1996	25122
Uchida et al. 1996	25135
Uchida	25135
et al.	25142
1996	25149
Bruses 2000	25155
Bruses	25155
2000	25162
Silencing N-cadherin using siRNA	25169
Silencing N-cadherin	25169
siRNA	25196
distinct biological effects on the interactions of SCs and OECs	25206
distinct biological effects	25206
the interactions of SCs and OECs	25237
the interactions	25237
SCs and OECs	25257
astrocytes	25275
co-culture of SCs and astrocytes	25290
co-culture	25290
SCs and astrocytes	25304
suppression of N-cadherin	25324
suppression	25324
N-cadherin	25339
heterotypic and homotypic adhesion	25358
they	25397
adhesion properties	25409
OECs	25442
contrast	25451
N-cad siRNA transfection into OECs	25461
N-cad siRNA transfection	25461
OECs	25491
little effect on their migration and adhesion	25500
little effect	25500
their migration and adhesion	25517
astrocytes	25565
These findings	25577
N-cadherin	25603
SCs and OECs -LRB- Fairless , et al. 2005 -RRB-	25645
SCs and OECs	25645
Fairless , et al. 2005	25659
Fairless , et al.	25659
Fairless	25659
et al.	25669
2005	25676
translocation of nuclear factor kappa B , a key transcriptional regulator of inflammatory genes ,	25705
translocation	25705
nuclear factor kappa B , a key transcriptional regulator of inflammatory genes ,	25722
nuclear factor kappa B	25722
a key transcriptional regulator of inflammatory genes	25746
a key transcriptional regulator	25746
inflammatory genes	25781
astrocyte nuclei	25804
OECs releasing insulin-like growth factor-1	25824
OECs	25824
insulin-like growth factor-1	25839
one of the reasons leading to different reactions between SCs andOECs with astrocytes -LRB- Hale et al. 2011 -RRB-	25876
one	25876
the reasons leading to different reactions between SCs andOECs with astrocytes -LRB- Hale et al. 2011 -RRB-	25883
the reasons	25883
different reactions between SCs andOECs with astrocytes -LRB- Hale et al. 2011 -RRB-	25906
different reactions	25906
SCs andOECs with astrocytes -LRB- Hale et al. 2011 -RRB-	25934
SCs andOECs	25934
astrocytes -LRB- Hale et al. 2011 -RRB-	25951
astrocytes	25951
Hale	25963
et al. 2011	25968
et al.	25968
2011	25975
the previous studies	25985
it	26007
SCs	26034
OECs for transplant-mediated repair of injured spinal cord , based on the different interactions of SCs and OECs with astrocytes and biological behavior after transplantation -LRB- Lakatos et al. 2000 , 2003 ; Fairless et al. 2005 -RRB-	26060
OECs	26060
transplant-mediated repair of injured spinal cord	26069
transplant-mediated repair	26069
injured spinal cord	26099
the different interactions of SCs and OECs	26129
the different interactions	26129
SCs and OECs	26159
astrocytes and biological behavior	26177
astrocytes	26177
biological behavior	26192
transplantation -LRB- Lakatos et al. 2000 , 2003 ; Fairless et al. 2005 -RRB-	26218
transplantation	26218
Lakatos	26235
et al. 2000 , 2003 ; Fairless et al. 2005	26243
et al.	26243
2000 , 2003 ; Fairless et al. 2005	26250
2000 , 2003	26250
2000	26250
2003	26256
Fairless et al. 2005	26262
Fairless	26262
et al.	26271
2005	26278
SCs	26293
astrocytes	26305
more	26325
more	26355
OECs	26373
transplantation	26388
the present study	26419
both cells	26442
the axons	26467
the injured regions	26501
the function of the contused spinal cords demonstrated by BBB score and CSEP recording	26533
the function	26533
the contused spinal cords demonstrated by BBB score and CSEP recording	26549
the	26549
spinal cords demonstrated by BBB score and CSEP recording	26562
spinal cords	26562
BBB score and CSEP recording	26591
BBB score	26591
CSEP recording	26605
the data of either BBB score or CSEP recording	26630
the data	26630
either BBB score or CSEP recording	26642
BBB score	26649
CSEP recording	26662
recovery of the function in the SCs group	26689
recovery	26689
the function in the SCs group	26701
the function	26701
the SCs group	26717
that in the OECs group	26751
that	26751
the OECs group	26759
no statistical difference	26775
the groups	26827
SCs	26853
cell-mediated repair	26880
Previous studies	26902
both SCs and OECs	26952
SCs	26957
OECs	26965
the structure and function of the injured spinal cord	26982
the structure and function	26982
the injured spinal cord	27012
review	27041
Bunge 2008 ; Kocsis et al. 2009	27053
Bunge 2008	27053
Kocsis et al. 2009	27065
Kocsis	27065
et al.	27072
2009	27079
the study	27096
Takami et al. -LRB- 2002 -RRB- showed that a SCs graft is more effective in promoting axonal sparing/regeneration	27119
Takami	27119
et al. -LRB- 2002 -RRB-	27126
et al.	27126
2002	27134
a SCs graft	27152
axonal sparing/regeneration	27195
hind limb locomotor performance than a OECs graft in the moderately contused thoracic spinal cord	27240
hind limb locomotor performance	27240
a OECs graft in the moderately contused thoracic spinal cord	27277
a OECs graft	27277
the moderately contused thoracic spinal cord	27293
the chronic contusive spinal cord	27342
the transplanted SCs	27377
a substantive graft within the injury site	27403
a substantive graft	27403
the injury site	27430
the ingrowth of axons	27468
the ingrowth	27468
axons	27484
growth of both ascending calcitonin generelated peptide-positive and supraspinal serotonergic axons and increasing corticospinal axon numbers	27494
growth	27494
both ascending calcitonin generelated peptide-positive and supraspinal serotonergic axons and increasing corticospinal axon numbers	27504
both	27504
calcitonin generelated peptide-positive and supraspinal serotonergic axons	27519
calcitonin	27519
peptide-positive and supraspinal serotonergic axons	27542
corticospinal axon numbers	27609
the injury -- graft site	27659
the injury	27659
graft site	27670
SCs ' grafted animals	27692
SCs '	27692
modest improvements	27726
open field locomotion	27749
less foot position errors -LRB- Barakat et al. 2005 -RRB-	27785
less foot position errors	27785
Barakat	27812
et al. 2005	27820
et al.	27820
2005	27827
These regenerated axons induced by SCs ' transplantation	27834
These regenerated axons	27834
SCs ' transplantation	27869
SCs '	27869
measurable evoked responses following electrical stimulation -LRB- Pinzon et al. 2001 -RRB-	27915
measurable	27915
responses following electrical stimulation -LRB- Pinzon et al. 2001 -RRB-	27933
responses	27933
electrical stimulation -LRB- Pinzon et al. 2001 -RRB-	27953
electrical stimulation	27953
Pinzon	27977
et al. 2001	27984
et al.	27984
2001	27991
Such a restorative role for SCs	27998
Such a restorative role	27998
SCs	28026
their	28047
neurotrophic factors such as NGF -LRB- Bandtlow et al. 1987 -RRB- , BDNF -LRB- Acheson et al. 1991 ; Meyer et al. 1992 -RRB- , CNTF -LRB- Friedman et al. 1992 ; Rende et al. 1992 -RRB- , and GDNF -LRB- Widenfalk et al. 2001 -RRB- , which may diffuse into the contiguous host cord and promote the axon to regenerate and sprout	28064
neurotrophic factors	28064
NGF -LRB- Bandtlow et al. 1987 -RRB- , BDNF -LRB- Acheson et al. 1991 ; Meyer et al. 1992 -RRB- , CNTF -LRB- Friedman et al. 1992 ; Rende et al. 1992 -RRB- , and GDNF -LRB- Widenfalk et al. 2001 -RRB- , which may diffuse into the contiguous host cord and promote the axon to regenerate and sprout	28093
NGF -LRB- Bandtlow et al. 1987 -RRB- , BDNF -LRB- Acheson et al. 1991 ; Meyer et al. 1992 -RRB- , CNTF -LRB- Friedman et al. 1992 ; Rende et al. 1992 -RRB- , and GDNF -LRB- Widenfalk et al. 2001 -RRB-	28093
NGF -LRB- Bandtlow et al. 1987 -RRB-	28093
NGF	28093
Bandtlow	28098
et al. 1987	28107
et al.	28107
1987	28114
BDNF -LRB- Acheson et al. 1991 ; Meyer et al. 1992 -RRB-	28121
BDNF	28121
Acheson	28127
et al. 1991 ; Meyer et al. 1992	28135
et al. 1991 ; Meyer et al.	28135
et al. 1991	28135
et al.	28135
1991	28142
Meyer et al.	28148
Meyer	28148
et al.	28154
1992	28161
CNTF -LRB- Friedman et al. 1992 ; Rende et al. 1992 -RRB-	28168
CNTF	28168
Friedman	28174
et al. 1992 ; Rende et al. 1992	28183
et al. 1992 ; Rende et al.	28183
et al. 1992	28183
et al.	28183
1992	28190
Rende et al.	28196
Rende	28196
et al.	28202
1992	28209
GDNF -LRB- Widenfalk et al. 2001 -RRB-	28220
GDNF	28220
Widenfalk	28226
et al. 2001	28236
et al.	28236
2001	28243
the contiguous host cord	28273
the axon to regenerate and sprout	28310
SCs	28359
OECs	28364
BDNF , NGF , GDNF , and NT-4 / 5 -LRB- Woodhall et al. 2001 ; Boruch et al. 2001 -RRB-	28377
BDNF , NGF , GDNF , and NT-4 / 5	28377
BDNF , NGF , GDNF , and NT-4	28377
5	28403
Woodhall	28406
et al. 2001 ; Boruch et al. 2001	28415
et al. 2001 ; Boruch et al.	28415
et al. 2001	28415
et al.	28415
2001	28422
Boruch et al.	28428
Boruch	28428
et al.	28435
2001	28442
addition to the distribution and migration of the transplanted cells	28458
addition	28458
the distribution and migration of the transplanted cells	28470
the distribution and migration	28470
the transplanted cells	28504
neurotrophic factors released by them	28528
neurotrophic factors	28528
them	28561
the structure and function of the contused spinal cord	28592
the structure and function	28592
the contused spinal cord	28622
the	28622
spinal cord	28635
summary	28651
our results from the contusion SCI model	28660
our results	28660
the contusion SCI model	28677
the previous observations from the dorsal crush , transection injury , and normal white matter of the spinal cord that SCs graft induced more host astrocyte response and GFAP expression compared to OECs graft	28709
the previous observations from the dorsal crush	28709
the previous observations	28709
the dorsal crush	28740
transection injury	28758
normal white matter of the spinal cord that SCs graft induced more host astrocyte response and GFAP expression compared to OECs graft	28782
normal white matter	28782
the spinal cord	28805
graft	28830
host astrocyte response and GFAP expression compared to OECs graft	28849
host astrocyte response and GFAP expression	28849
OECs graft	28905
it	28926
SCs	28970
OECs	29020
the contused spinal cord	29032
the	29032
spinal cord	29045
the myelinated axons	29077
the groups	29118
the glial membrane in the SCs cord	29132
the glial membrane	29132
the SCs cord	29154
the OECs cord	29179
it	29206
the SCs group	29223
both SCs and OECs	29238
NF expression	29270
the function of the contused spinal cord	29296
the function	29296
the contused spinal cord	29312
the	29312
spinal cord	29325
SCs	29341
a valuable candidate for cell-mediated repair of the injured spinal cord	29361
a valuable candidate	29361
cell-mediated repair of the injured spinal cord	29386
cell-mediated repair	29386
the injured spinal cord	29410
maximal benefit	29455
the recovery of the injured spinal cord	29475
the recovery	29475
the injured spinal cord	29491
a combinative transplantation of SCs and OECs with some factors for promoting cell migration and axon regeneration	29516
a combinative transplantation	29516
SCs and OECs with some factors for promoting cell migration and axon regeneration	29549
SCs and OECs	29549
some factors for promoting cell migration and axon regeneration	29567
some factors	29567
cell migration and axon regeneration	29594
cell migration	29594
axon regeneration	29613
the future	29654
